BRIGHT MINDS BIOSCIENCES INC. (DRUG)
B
Pipeline Grade
Drug Pipeline (1 Assets)
| Drug | Phase | Indications |
|---|---|---|
|
FLUTICASONE PROPIONATE
FLUTICASONE PROPIONATE |
NDA | Absence Epilepsy, Dravet Syndrome, Healthy, Jeavons Syndrome, Lennox-Gastaut Syndrome, Prader-Willi Syndrome |
Upcoming Catalysts
No upcoming catalysts detected for this company.
Active Clinical Trials (1)
| NCT # | Title | Phase | Status | Enrollment |
|---|---|---|---|---|
| NCT06401538 | BMB-101 in Absence Epilepsy and DEE | PHASE2 | Recruiting | 20 |
Source: ClinicalTrials.gov. Trial status last updated by sponsor — may not reflect current state.